BWBilly J. Williams-Noonan

Billy J. Williams-Noonan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Billy J. Williams-Noonan has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Computational Lipidomics Reveals Environment-Specific Membrane Remodeling in Prostate Cancer

    by Yumeng Hao, Billy J. Williams-Noonan, Patrick Sutton, Reuben S. E. Young, Stephen J. Blanksby, Evelyne Deplazes, Megan L. O’mAra

    Metabolic changes during cancer progression produce key differences in phospholipid distributions among normal (RWPE-1), benign hyperplasia (BPH-1), and metastatic prostate (lymph: LNCaP, bone: PC-3, and brain: DU145) cell lines that are markers of disease progression and cancer cell adaptation (Young et al., 2021). The effect of cancer-associated lipidome shifts on membrane structural dynamics has not been investigated in a cell-specific context. Here, we spatially map the specific membrane lipidome from each cell line data set to assess membrane organization and dynamics in normal, benign hyperplasia, and metastatic prostate cell lines. Long time scale molecular dynamics simulations show leaflet-specific alterations in membrane dynamics, with increased fluidity in the intracellular leaflet of metastatic membranes. All membranes exhibited phase-separated domains enriched in polyunsaturated lipids and depleted in cholesterol; however, the extent of phase separation varied with disease state. Specifically, the loss of phosphatidylserine lipid leaflet asymmetry in metastatic cell membranes decreased the level of phospholipid phase separation. In particular, the metastatic LNCaP lymph node cell line showed exaggerated phase separation for distinct phospholipid species compared to all other metastatic and noncancerous lines. These alterations in lipid colocalization and phase separation patterns across prostate cancer cell membrane lines suggest environment-specific adaptations that may play a role in cancer progression.


  • Open Access

    A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects

    by Ryan P. Cantwell Chater, Julian Peiser-Oliver, Tanmay K. Pati, Ada S. Quinn, Irina Lotsaris, Zachary J. Frangos, Kristen E. Anderson, Anna E. Tischer, Billy J Williams-Noonan, Karin R. Aubrey, et al.

    Chronic neuropathic pain, caused by nerve damage or disease, is increasing in prevalence, but current treatments are ineffective and over-reliant on opioids. The neuronal glycine transporter, GlyT2, regulates inhibitory glycinergic neurotransmission and represents a promising target for new analgesics. However, most GlyT2 inhibitors cause significant side effects, in part due to irreversible inhibition at analgesic doses. Here we develop a reversible inhibitor of GlyT2, RPI-GLYT2-82, and identify its binding site by determining cryo-EM structures of human GlyT2. We capture three fundamental conformational states of GlyT2 in the substrate-free state, and bound to either glycine, RPI-GLYT2-82 or the pseudo-irreversible inhibitor ORG25543. We demonstrate that RPI-GLYT2-82 dissociates from GlyT2 faster than ORG25543, providing analgesia in mouse neuropathic pain models without on-target side-effects or addiction liability. Our data provide a mechanistic understanding of allosteric inhibition of glycine transport, enabling structure-based design of non-opioid analgesics.


  • Open Access

    Atomic Scale Structure of Self‐Assembled Lipidated Peptide Nanomaterials

    by Billy J. Williams‐Noonan, Ketav Kulkarni, Nevena Todorova, Matteo Franceschi, Christopher Wilde, Mark P. Del Borgo, Louise C. Serpell, Marie‐Isabel Aguilar, Irene Yarovsky

    β‐Peptides have great potential as novel biomaterials and therapeutic agents, due to their unique ability to self‐assemble into low dimensional nanostructures, and their resistance to enzymatic degradation in vivo. However, the self‐assembly mechanisms of β‐peptides, which possess increased flexibility due to the extra backbone methylene groups present within the constituent β‐amino acids, are not well understood due to inherent difficulties of observing their bottom‐up growth pathway experimentally. A computational approach is presented for the bottom‐up modelling of the self‐assembled lipidated β3‐peptides, from monomers, to oligomers, to supramolecular low‐dimensional nanostructures, in all‐atom detail. The approach is applied to elucidate the self‐assembly mechanisms of recently discovered, distinct structural morphologies of low dimensional nanomaterials, assembled from lipidated β3‐peptide monomers. The resultant structures of the nanobelts and the twisted fibrils are stable throughout subsequent unrestrained all‐atom molecular dynamics simulations, and these assemblies display good agreement with the structural features obtained from X‐ray fiber diffraction and atomic force microscopy data. This is the first reported, fully‐atomistic model of a lipidated β3‐peptide‐based nanomaterial, and the computational approach developed here, in combination with experimental fiber diffraction analysis and atomic force microscopy, will be useful in elucidating the atomic scale structure of self‐assembled peptide‐based and other supramolecular nanomaterials.


  • Open Access

    Self-assembling peptide biomaterials: Insights from spontaneous and enhanced sampling molecular dynamics simulations

    by Billy J. Williams-Noonan, Alexa Kamboukos, Nevena Todorova, Irene Yarovsky

    Peptide self-assembly is the process by which peptide molecules aggregate into low dimensional (1D, 2D) or 3D ordered materials with potential applications ranging from drug delivery to electronics. Short peptides are particularly good candidates for forming supramolecular assemblies due to the relatively simple structure and ease of modulating their self-assembly process to achieve required material properties. The experimental resolution of fibrous peptide-based nanomaterials as 3D atomic coordinates remains challenging. For surface-mediated peptide assembly in particular, it is typically not feasible to resolve multiple conformationally distinct surface bound peptide structures by experiment. The mechanisms of peptide self-assembly also remain elusive due to the interchange of complex interactions and multiple time and length scales involved in the self-assembly process. Peptide self-assembly in solution, or mediated by surfaces, is driven by specific interactions between the peptides and water, competing interactions within the peptide and/or between peptide aggregate units and, in the latter case, an interplay of the interactions between peptides and solvent molecules for adsorption onto a proximal surface. Computational methodologies have proven beneficial in elucidating the structures formed during peptide self-assembly and the molecular mechanisms driving it, and hence have scope in facilitating the development of functional peptide-based nanomaterials for medical or biotechnological applications. In this perspective, computational methods that have provided molecular insights into the mechanisms of formation of peptide biomaterials, and the all-atom-resolved structures of peptide assemblies are presented. Established and recently emerged molecular simulation approaches are reviewed with a focus on applications relevant to peptide assembly, including all-atom and coarse-grained “brute force” molecular dynamics methods as well as the enhanced sampling methodologies: umbrella sampling, steered and replica exchange molecular dynamics, and variants of metadynamics. These approaches have been shown to contribute all-atom details not yet available experimentally, to advance our understanding of peptide self-assembly processes and biomaterial formation. The scope of this review includes a summary of the current state of the computational methods, in terms of their strengths and limitations for application to self-assembling peptide biomaterials.


  • Open Access

    Relative Binding Free Energy Predictions for Inhibitors of Tetrameric Influenza Virus Neuraminidase

    by Billy J Williams-Noonan, Elizabeth Yuriev, David K Chalmers

    Accurate methods to predict the free energies of protein-ligand interactions have great potential to assist rational drug design. In this work, we used molecular dynamics simulations with alchemical perturbation to predict the binding of carbohydrate-based ligands to influenza virus neuraminidase (N2). This specific drug target is a challenging test system for alchemical free energy methods because it has flexible binding site motifs. We use a molecular dynamics protocol that works for longer time scales than are often reported in previous molecular dynamics studies of N2. We demonstrated that N2-ligand complex stability and that accurate N2 150-loop dynamics, on a 350 ns time scale, are both force field-dependent (AMBER99SB-ILDN, GAFF and TIP4P water are required). Further, we showed that crystallographic waters must be retained to maintain stability of N2-ligand complexes over 350 ns. Using our modelling protocol, we were able to determine relative binding free energy values between neuraminidase ligands which correlated strongly with experimental differences in pIC50 values (R = -0.96, ρ = 0.86, N = 13, sig < 0.0001). It is anticipated that the molecular dynamics protocol and the relative binding free energy methods reported here, will both be useful in expediting the discovery of novel therapeutics for N2 and other homologous glycohydrolases.